225 related articles for article (PubMed ID: 35205414)
1. Analysing miRNA-Target Gene Networks in Inflammatory Bowel Disease and Other Complex Diseases Using Transcriptomic Data.
Thomas JP; Ölbei M; Brooks-Warburton J; Korcsmaros T; Modos D
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205414
[TBL] [Abstract][Full Text] [Related]
2. Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling.
Palmieri O; Creanza TM; Bossa F; Latiano T; Corritore G; Palumbo O; Martino G; Biscaglia G; Scimeca D; Carella M; Ancona N; Andriulli A; Latiano A
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726756
[TBL] [Abstract][Full Text] [Related]
3. Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
Alfaifi J; Germain A; Heba AC; Arnone D; Gailly L; Ndiaye NC; Viennois E; Caron B; Peyrin-Biroulet L; Dreumont N
Inflamm Bowel Dis; 2023 Jun; 29(6):986-999. PubMed ID: 36545755
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
5. Discovery of inflammatory bowel disease-associated miRNAs using a novel bipartite clustering approach.
Altaf-Ul-Amin M; Karim MB; Hu P; Ono N; Kanaya S
BMC Med Genomics; 2020 Feb; 13(Suppl 3):10. PubMed ID: 32093721
[TBL] [Abstract][Full Text] [Related]
6. Differential Gene Expression Profiles Involved in the Inflammations Due to COVID-19 and Inflammatory Bowel Diseases and the Investigation of Predictive Biomarkers.
Aishwarya S; Gunasekaran K
Biochem Genet; 2024 Feb; 62(1):311-332. PubMed ID: 37335372
[TBL] [Abstract][Full Text] [Related]
7. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease.
Yarani R; Shojaeian A; Palasca O; Doncheva NT; Jensen LJ; Gorodkin J; Pociot F
Front Immunol; 2022; 13():865777. PubMed ID: 35734163
[TBL] [Abstract][Full Text] [Related]
8. Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease.
Soroosh A; Koutsioumpa M; Pothoulakis C; Iliopoulos D
Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G256-G262. PubMed ID: 29146677
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics.
Coskun M; Bjerrum JT; Seidelin JB; Nielsen OH
World J Gastroenterol; 2012 Sep; 18(34):4629-34. PubMed ID: 23002331
[TBL] [Abstract][Full Text] [Related]
10. microRNA-mRNA Networks Linked to Inflammation and Immune System Regulation in Inflammatory Bowel Disease.
Síbia CF; Quaglio AEV; Oliveira ECS; Pereira JN; Ariede JR; Lapa RML; Severino FE; Reis PP; Sassaki LY; Saad-Hossne R
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398024
[TBL] [Abstract][Full Text] [Related]
11. Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models.
Suri K; Bubier JA; Wiles MV; Shultz LD; Amiji MM; Hosur V
Cells; 2021 Aug; 10(9):. PubMed ID: 34571853
[TBL] [Abstract][Full Text] [Related]
12. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?
Aggeletopoulou I; Mouzaki A; Thomopoulos K; Triantos C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768556
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases.
Clark PM; Dawany N; Dampier W; Byers SW; Pestell RG; Tozeren A
Inflamm Bowel Dis; 2012 Dec; 18(12):2315-33. PubMed ID: 22488912
[TBL] [Abstract][Full Text] [Related]
15. microRNA in inflammatory bowel disease at a glance.
Alamdari-Palangi V; Vahedi F; Shabaninejad Z; Dokeneheifard S; Movehedpour A; Taheri-Anganeh M; Savardashtaki A
Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):140-148. PubMed ID: 32558695
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs: how many in inflammatory bowel disease?
Schaefer JS
Curr Opin Gastroenterol; 2016 Jul; 32(4):258-66. PubMed ID: 27138057
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-132 and microRNA-223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease.
Kim HY; Kwon HY; Ha Thi HT; Lee HJ; Kim GI; Hahm KB; Hong S
J Gastroenterol Hepatol; 2016 Oct; 31(10):1727-1735. PubMed ID: 26878986
[TBL] [Abstract][Full Text] [Related]
18. Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease.
Iborra M; Bernuzzi F; Correale C; Vetrano S; Fiorino G; Beltrán B; Marabita F; Locati M; Spinelli A; Nos P; Invernizzi P; Danese S
Clin Exp Immunol; 2013 Aug; 173(2):250-8. PubMed ID: 23607522
[TBL] [Abstract][Full Text] [Related]
19. Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis.
Lee J; Park EJ; Yuki Y; Ahmad S; Mizuguchi K; Ishii KJ; Shimaoka M; Kiyono H
Sci Rep; 2015 Dec; 5():18174. PubMed ID: 26647826
[TBL] [Abstract][Full Text] [Related]
20. Role of MiRNAs in Inflammatory Bowel Disease.
Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
